"The offering price per share of our common stock less any underwriting commissions or discounts will generally not be less than the net asset value per share of our common stock at the time we make the offering."
and I don't generally pay $7.00 a gallon for gas but would under the right circumstances.
We may offer, from time to time, up to $10,000,000 of our common stock, preferred stock, subscription rights to purchase shares of our common stock, debt securities, and warrants representing rights to purchase shares of our common stock, preferred stock or debt securities on terms to be determined at the time of the offering and set forth in one or more supplements to this prospectus
about a 10% dilution? does TINY trade down to $2.50?
--Lowered Expectations-- but still a little good news.
."OpGen Sets New Price Range on Planned IPO; Sharply Lowers Anticipated Proceeds
Apr 24, 2015 | a GenomeWeb staff reporter
NEW YORK (GenomeWeb) – OpGen lowered the price range on its planned initial public offering, resulting in a sharp drop in its anticipated net proceeds.
In an amended prospectus filed with the US Securities and Exchange Commission on Thursday, the microbial genetics analysis firm said it anticipates offering 2.5 million units in its IPO at between $5.50 and $6.50 per unit, with net proceeds expected at about $12.6 million at the midpoint price of $6 per unit. Each unit consists of one share of OpGen's common stock and one warrant to purchase an additional share.
If the offering's underwriter, the Maxim Group, exercises its overallotment option in full, net proceeds are estimated to be $14.7 million.
Earlier this month, OpGen said that it planned to offer 3.75 million shares of its common stock in the IPO at a range of $8 to $10 per share, which would have resulted in net proceeds of about $30.5 million, or $35.2 million if the overallotment option was exercised in full. It filed to go public in March.
"As of December 31, 2014, we valued the remaining potential milestone payments from the sale of BioVex Group, Inc., at $2,564,917. If all the remaining milestone payments were to be paid by Amgen, Inc., we would receive an additional $7,455,438. There can be no assurance as to the timing and how much of this amount we will ultimately realize in the future."
can't find any mention of possible future royalties. can you? tia